Ossifying fibromyxoid tumor: An update

29Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain differentiation, initially described by Enzinger and colleagues. Until now, nearly 300 such cases have been reported worldwide. The histogenesis of these tumors remains controversial. These tumors show characteristic imaging findings and exhibit a spectrum of histopathologic features, including classical and atypical subtypes. Local recurrences and, occasionally, distant metastases have also been reported. A complete tumor resection forms the preferred treatment modality for these tumors, along with follow-up, as these tumors have an uncertain malignant potential. Lately, certain "molecular signatures" underlying OFMTs have been described that can further aid in reaching an accurate diagnosis for these tumors and unraveling their pathogenesis. This article is a review of the clinical, radiologic, histopathologic, and molecular features of OFMTs.

Cite

CITATION STYLE

APA

Bakiratharajan, D., & Rekhi, B. (2016, April 1). Ossifying fibromyxoid tumor: An update. Archives of Pathology and Laboratory Medicine. College of American Pathologists. https://doi.org/10.5858/arpa.2014-0590-RS

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free